Literature DB >> 9657070

Regulation of the 11 beta-hydroxysteroid dehydrogenase in the rat adrenal. Decrease enzymatic activity induced by ACTH.

H Morita1, E N Cozza, M Y Zhou, E P Gomez-Sanchez, D G Romero, C E Gomez-Sanchez.   

Abstract

Patients with ectopic ACTH syndrome often develop hypertension and hypokalemic alkalosis with an abnormal increase in the ratio of plasma cortisol to cortisone, indicating that 11 beta-hydroxysteroid dehydrogenase (11 beta HSD) activity is inhibited. Inhibition of 11 beta HSD allows access of cortisol or corticosterone to the mineralocorticoid receptor where it act as a mineralocorticoid. Two isozymes, 11 beta HSD-1 and 11 beta HSD-2, have been cloned and characterized. The rat adrenal expresses the mRNAs for 11 beta HSD-2 and, in lesser amounts, 11 beta HSD-1. We investigated the effect of ACTH on the 11 11 beta HSD-2 activity in the rat adrenal. Rat adrenal cells zone fasciculata (ZF) were dispersed and incubated separately with increasing concentrations of ACTH for 90 min, and secretion of corticosterone (B) and 11-dehydrocorticosterone (A) in the media was measured by enzyme-linked immunoabsorbent assays (ELISA). The conversion of [3H]B to [3H]A in the presence of 0.5 mM NAD+ was evaluated in microsomes prepared from dispersed cells preincubated for 30 min with cyanoketone and metyrapone followed by incubation for 30 min with the same inhibitors, with and without 10 nM ACTH. The dispersed cells of the ZF produced significant amounts of A which increased with ACTH. The basal B/A ratio was 0.97 +/- 0.05. ACTH caused a concentration-dependent increase in the ratio of B/A with a maximum ratio of 9.58 +/- 0.20. ACTH also inhibited the conversion of [3H]B to [3H]A in microsomes in which endogenous B production was inhibited by cyanoketone and metyrapone. ACTH did not change the K(m) for B conversion, but the Vmax was reduced significantly (1.73 +/- 0.43 pmol/min. mg protein), indicating that ACTH suppressed the 11 beta HSD-2 in a noncompetitive fashion. Dibutyryl cyclic AMP (dcAMP) also produced a concentration-dependent increase in the B/A ratio, but various concentrations of calcium did not affect the enzyme activity. In summary, adrenal cells treated with ACTH results in a significant increase in the ratio of B/A in the ZF owing a noncompetitive inhibition of the 11 beta HSD-2 via the ACTH receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9657070     DOI: 10.1007/BF02801327

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

1.  The intrarenal localization of mineralocorticoid receptors and 11 beta-dehydrogenase: immunocytochemical studies.

Authors:  S E Rundle; J W Funder; V Lakshmi; C Monder
Journal:  Endocrinology       Date:  1989-09       Impact factor: 4.736

2.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

Authors:  J L Arriza; C Weinberger; G Cerelli; T M Glaser; B L Handelin; D E Housman; R M Evans
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

3.  Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.

Authors:  J W Funder; P T Pearce; R Smith; A I Smith
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

4.  Conversion of corticosterone to 11-dehydrocorticosterone by adrenal gland preparations of different animal species.

Authors:  A G Fazekas; T Sandor; A Lanthier
Journal:  Endocrinology       Date:  1970-02       Impact factor: 4.736

5.  Cushing's syndrome and hypertension.

Authors:  C E Gomez-Sanchez
Journal:  Hypertension       Date:  1986-03       Impact factor: 10.190

6.  Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies.

Authors:  B L Roland; Z S Krozowski; J W Funder
Journal:  Mol Cell Endocrinol       Date:  1995-04-28       Impact factor: 4.102

7.  Expression cloning of the aldosterone target cell-specific 11 beta-hydroxysteroid dehydrogenase from rabbit collecting duct cells.

Authors:  A Náray-Fejes-Tóth; G Fejes-Tóth
Journal:  Endocrinology       Date:  1995-06       Impact factor: 4.736

8.  Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.

Authors:  B R Walker; J C Campbell; R Fraser; P M Stewart; C R Edwards
Journal:  Clin Endocrinol (Oxf)       Date:  1992-12       Impact factor: 3.478

9.  Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid.

Authors:  S Teelucksingh; A D Mackie; D Burt; M A McIntyre; L Brett; C R Edwards
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

10.  Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action.

Authors:  C B Whorwood; M C Sheppard; P M Stewart
Journal:  Endocrinology       Date:  1993-06       Impact factor: 4.736

View more
  3 in total

1.  Effects of CRH and ACTH administration on plasma and brain neurosteroid levels.

Authors:  J M Torres; E Ruiz; E Ortega
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

2.  Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.

Authors:  Pablo Stiefel; José S García-Morillo; Luis Jimenez; Encarnación Pamies; María Luisa Miranda; Joaquín Carneado; José Villar; Alfonso Leal-Cerro
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

3.  A Rat Model of Post-Traumatic Stress Syndrome Causes Phenotype-Associated Morphological Changes and Hypofunction of the Adrenal Gland.

Authors:  Vadim Tseilikman; Maria Komelkova; Marina V Kondashevskaya; Eugenia Manukhina; H Fred Downey; Valerii Chereshnev; Margarita Chereshneva; Pavel Platkovskii; Anna Goryacheva; Anton Pashkov; Julia Fedotova; Olga Tseilikman; Natalya Maltseva; Olga Cherkasova; Charlotte Steenblock; Stefan R Bornstein; Barbara Ettrich; George P Chrousos; Enrico Ullmann
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.